Chongqing, China - June 13, 2025 - Porton Pharma Solutions announced today that its Changshou plant, a key facility for making small molecule drugs, received a top "Gold" EcoVadis sustainability rating. This puts it in the top 5% of companies globally.
Thank you for reading this post, don't forget to subscribe!This achievement not only represents a strong endorsement of Porton’s long-term practices in sustainable development, but also highlights its responsibility in the global pharmaceutical industry chain.
As a global leader in sustainability assessment, EcoVadis has provided authoritative rating services for more than 150,000 enterprises. It provides a critical metric for evaluating company's sustainability management system. Porton’s Changshou site scored 79 (out of 100) in the latest assessment, with particularly outstanding performance in Environment and Labor & Human Rights.
Porton is dedicated to embedding sustainability into its corporate strategy and operations. Porton joined the United Nations Global Compact (UNGC) in 2017, formally pledging to uphold its Ten Principles. In 2024, Porton further expanded its sustainable program portfolio. In 2025, Porton got its scientifically-backed greenhouse gas reduction goals officially approved by SBTi, demonstrating its commitment to sustainable development. Porton also announced its sustainability targets recently, covering energy consumption, water resources, and waste management.
Porton will further advance its sustainability strategy. And we will catalyze the global pharmaceutical green transition through excellent practice sharing.
